List view / Grid view

Oryzon

Filter the results

 

news

ORYZON appoints Greg Weaver as Global Chief Financial Officer

12 January 2015 | By Oryzon

Oryzon Genomics SA, a clinical stage biopharmaceutical company developing therapeutics in oncology and CNS diseases based on its proprietary epigenetics technology platform, announced the appointment of Gregory L. Weaver as Executive Vice President and Chief Financial Officer, effective January 12, 2015...